Hexagon Nutrition Ltd. Clarifies Financial Results Post-NSE Query
Hexagon Nutrition Limited clarified financial reporting issues to NSE for the quarter/year ended March 31, 2026. Corrected XBRL reserves to ₹2222.30 million and re-submitted machine-readable results. The company reported total income of ₹3,945.66 million and net profit of ₹379.37 million for the year.
This announcement addresses routine regulatory compliance and clarification of previously submitted financial data. It does not introduce new material business developments, significant financial changes, or strategic shifts that would significantly impact the company's valuation or operations.
The announcement is a clarification of previously submitted financial results and addresses technical and formatting errors. While the core financial performance information is provided, the primary focus is on rectifying reporting discrepancies rather than announcing new positive developments.
Hexagon Nutrition Limited has provided clarifications to the National Stock Exchange of India (NSE) regarding its financial results for the quarter and year ended March 31, 2026. The company addressed issues related to the submission of machine-readable financial results, format discrepancies in the Limited Review/Auditor's Report, and a mismatch in XBRL filings concerning reserves. The company has re-submitted a searchable PDF of its financial results and auditor's report. It also clarified that separate UDINs are required for standalone and consolidated reports, rectifying a previous typographical error. Furthermore, a typo during XBRL generation caused a reserves mismatch, which has been corrected to ₹2222.30 million. The auditor's report highlights several key points including the merger of a wholly-owned subsidiary, conversion of CCPS to equity shares, the company's IPO and listing, and material uncertainty regarding the going concern status of two foreign subsidiaries, though the holding company has committed to provide financial support.
The financial results for the year ended March 31, 2026, show total income of ₹3,945.66 million and a net profit of ₹379.37 million. The consolidated balance sheet as of March 31, 2026, indicates total assets of ₹3,184.03 million and total equity and liabilities of ₹3,184.03 million. The cash flow statement for the year ended March 31, 2026, reports net cash generated from operating activities of ₹62.31 million and net cash used in investing activities of ₹56.91 million.
What to do with a filing like this
Hexagon Nutrition Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Hexagon Nutrition Limited. Read the original for the full detail.